202 related articles for article (PubMed ID: 26512929)
21. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
Rivers JK
Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
[TBL] [Abstract][Full Text] [Related]
22. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
Çayirli M; Köse O; Demiriz M
Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
[TBL] [Abstract][Full Text] [Related]
23. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
Burkhart CN; Burkhart CG
Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
[No Abstract] [Full Text] [Related]
24. Diclofenac/hyaluronic acid.
Peters DC; Foster RH
Drugs Aging; 1999 Apr; 14(4):313-9; discussion 320-1. PubMed ID: 10319244
[TBL] [Abstract][Full Text] [Related]
25. Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation.
Malvehy J; Roldán-Marín R; Iglesias-García P; Díaz A; Puig S
Acta Derm Venereol; 2015 Jan; 95(1):45-50. PubMed ID: 24696069
[TBL] [Abstract][Full Text] [Related]
26. Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis.
Maltusch A; Röwert-Huber J; Matthies C; Lange-Asschenfeldt S; Stockfleth E
J Dtsch Dermatol Ges; 2011 Dec; 9(12):1011-7. PubMed ID: 21585654
[TBL] [Abstract][Full Text] [Related]
27. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
28. Topical diclofenac gel for the management of periocular actinic keratosis.
Batra R; Sundararajan S; Sandramouli S
Ophthalmic Plast Reconstr Surg; 2012; 28(1):1-3. PubMed ID: 21785377
[TBL] [Abstract][Full Text] [Related]
29. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
[TBL] [Abstract][Full Text] [Related]
30. Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
Cantisani C; Paolino G; Scarnò M; Didona D; Tallarico M; Moliterni E; Losco L; Cantoresi F; Mercuri SR; Bottoniτ U; Calvieri S
Dermatol Ther; 2018 Nov; 31(6):e12710. PubMed ID: 30253027
[No Abstract] [Full Text] [Related]
31. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
Van der Geer S; Krekels GA
J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
[TBL] [Abstract][Full Text] [Related]
32. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.
Wolf JE; Taylor JR; Tschen E; Kang S
Int J Dermatol; 2001 Nov; 40(11):709-13. PubMed ID: 11737438
[TBL] [Abstract][Full Text] [Related]
33. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
Vlachou C; Kanelleas AI; Martin-Clavijo A; Berth-Jones J
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1343-5. PubMed ID: 18554227
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil.
Segatto MM; Dornelles SI; Silveira VB; Frantz Gde O
An Bras Dermatol; 2013; 88(5):732-8. PubMed ID: 24173178
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial.
Yang CC; Wong TW; Lee CH; Hong CH; Chang CH; Lai FJ; Lin SH; Chi CC; Lin TK; Yen H; Wu CH; Sheu HM; Lan CE
J Dermatol Sci; 2018 Jun; 90(3):295-302. PubMed ID: 29530340
[TBL] [Abstract][Full Text] [Related]
36. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
Bettencourt MS
J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
[TBL] [Abstract][Full Text] [Related]
37. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
Berlin JM; Rigel DS
J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
[TBL] [Abstract][Full Text] [Related]
38. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
[TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
Berman B
Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
[TBL] [Abstract][Full Text] [Related]
40. 3% diclofenac in 2.5% hyaluronic acid (Solaraze) does not induce photosensitivity or phototoxicity alone or in combination with sunscreens.
Ortonne JP; Queille-Roussel C; Duteil L
Eur J Dermatol; 2006; 16(4):385-90. PubMed ID: 16935795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
